Kamarck Michael E. 4
4 · Vaxcyte, Inc. · Filed Oct 29, 2021
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Kamarck Michael E.
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-10-27+30,000→ 30,000 totalExercise: $22.02Exp: 2031-10-26→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]Option shall vest over 36 months, 1/3 of which will vest on October 27, 2022 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date